SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is facing intense scrutiny and volatility as the market reacts to the President's shifting rhetoric regarding a potential military pause in Iran. Community sentiment is deeply polarized, with critics pointing to portfolio losses and questioning the company's financial fundamentals, while supporters remain vocal about their backing of the administration's aggressive policy maneuvers.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing a significant sell-off driven by unfavorable court rulings in addiction-related lawsuits, which has triggered fears of widespread litigation and regulatory headwinds. While the company's fundamentals remain a focal point for many traders, the community is currently locked in a heated debate over whether this price action represents a temporary overreaction and buying opportunity or a deeper structural shift for the stock.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is seeing high volatility and heavy trading volume as investors debate the impact of new AI-driven tools on its long-term moat, while the company explores a potential sale of its China business to streamline operations and bolster its balance sheet. The community remains deeply divided, with bulls pointing to the growth potential of the Vector ad platform and future AI product reveals, while others express frustration over the stock's persistent decline and the competitive pressure from emerging AI-integrated workflows.

Pelican Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 23, 2024 and is headquartered in New York, NY.

Greenland Energy Co.

Greenland Energy is trending following the completion of its business combination and the appointment of former TD Ameritrade CEO Joe Moglia as an Executive Advisor. Community members are actively speculating on the stock's potential, fueled by reports of significant oil reserves in Greenland and high-profile partnerships, leading to heavy discussion regarding the company's long-term strategic value.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo Finance is trending as the community rallies around its high-profile partnership with Franklin Templeton to bring tokenized ETFs onto the blockchain. Investors are actively discussing the project's potential to bridge traditional finance with decentralized markets, fueling widespread optimism about its long-term growth and utility.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is trending following strong momentum in Rezdiffra prescriptions and ongoing M&A speculation, with investors closely watching the company's ability to maintain its market-leading position in the MASH space. The community is actively debating the stock's valuation as a potential buyout candidate versus the long-term growth potential of its expanding pipeline and combination therapy strategy.

Tidal Trust II - YieldMax TSLA Option Income Strategy ETF

YieldMax TSLA Option Income Strategy ETF

TSLY is currently trending as investors debate the sustainability of its high-yield option income strategy against ongoing NAV erosion. While some in the community highlight its role as a cashflow engine in a diversified portfolio, critics continue to emphasize concerns regarding reverse splits and long-term capital preservation.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp

GeneDx is experiencing significant volatility and intense community debate following a sharp price decline despite reporting strong revenue growth and raised guidance. Investors are actively discussing whether the sell-off presents a long-term accumulation opportunity or a signal of deeper structural concerns regarding company financials and insider activity.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is seeing heightened volatility as community discourse centers on Cathie Wood's aggressive rebalancing, including recent divestments from tech giants like Meta and Tesla. Investors are actively debating whether these tactical shifts signal a pivot to better risk management or a lack of conviction, while others view the current price compression at key technical support levels as a potential entry point for long-term growth exposure.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is seeing significant investor interest as the community focuses on its aggressive commercial expansion and the upcoming CVS formulary shift, which is expected to catalyze Vevye's growth. Enthusiastic shareholders are actively tracking sales force hiring and product launch timelines, with many viewing the stock as a prime opportunity for long-term growth as the company shifts toward a more mature, cash-generating phase.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Stock traders bought 1,002 put options on the stock. This...

Maravai LifeSciences (NASDAQ:MRVI) Sees Large Volume Increase - Still a Buy?

Maravai LifeSciences (NASDAQ:MRVI) Sees Large Volume Increase - Time to Buy...

Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the...

Royce & Associates LP Has $5.06 Million Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI

Royce & Associates LP boosted its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 38.0% in the 3rd quarter, according to its most recent filing with the...

First Eagle Investment Management LLC Makes New Investment in Maravai LifeSciences Holdings, Inc. $MRVI

First Eagle Investment Management LLC bought a new position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) during the 3rd quarter, according to the company in its most...

Maravai LifeSciences (NASDAQ:MRVI) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen raised Maravai LifeSciences from a "sell" rating to a "hold" rating in a research report on Saturday...

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up - Still a Buy?

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up - Here's What Happened...

Maravai LifeSciences Q4 Earnings Call Highlights

Maravai LifeSciences (NASDAQ:MRVI) executives told investors the company exited fiscal 2025 with improving operating leverage following a restructuring and a renewed emphasis on customer engagement...

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

Maravai LifeSciences (MRVI) delivered earnings and revenue surprises of +40.03% and +1.21%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Maravai LifeSciences (NASDAQ:MRVI) Issues Earnings Results, Beats Expectations By $0.03 EPS

Maravai LifeSciences (NASDAQ:MRVI - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.04) earnings per share for the quarter, beating the consensus...

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MRVI News

MRVIMaravai LifeSciences Holdings Inc - Ordinary Shares - Class A